Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03606486 · ClinicalTrials.gov registry record · NA
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
A NA study, sponsored by University of Washington.
- Terminated
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT03606486 is a NA study that was terminated before completion, run by University of Washington. The registered enrollment target is 52 participants.
The verdict
NCT03606486, a NA study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The goal of this project is to develop a minimally invasive test to detect ovarian cancer, by searching for mutations from the tumor in samples obtained from the cervix (Pap smears), and from the uterus (uterine lavage) in participants with advanced ovarian cancer and in participants with increased risk of ovarian cancer due to inherited mutations, such as BRCA or BRCA2 (among others). Pap smear and uterine lavage samples will be collected while the participant is under anesthesia for planned debulking surgery. A novel, highly sensitive and accurate technique, Crispr-Duplex sequencing, will be used to detect tumor associated mutations in TP53 (the most commonly mutated gene in ovarian cancer) within these samples. These results will be compared to sequencing results in the tumor itself for comparison, and Pap and uterine lavage will be compared to each other to determine the optimal test. Ultimately, the goal is to use the results of this study to plan a larger study including women without cancer who are at either increased risk or normal risk of ovarian cancer, for use in early detection.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Biospecimen Collection
- OTHER Pap Smear
- DEVICE Lavage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-11-16 |
| Est. Completion | 2022-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03606486
The ClinicalTrials.gov registry entry for NCT03606486 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03606486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03606486 about?
NCT03606486 is a clinical study titled "Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer". The goal of this project is to develop a minimally invasive test to detect ovarian cancer, by searching for mutations from the tumor in samples obtained from the cervix (Pap smears), and from the uterus (uterine lavage) in participants with advanced ovarian cancer and in participants with increased ...
What is the current status of trial NCT03606486?
This trial is currently terminated. It is a NA study. The enrollment target is 52 participants. The study started on 2018-11-16. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT03606486?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Biospecimen Collection (OTHER), Pap Smear (OTHER), Lavage (DEVICE).
Who is sponsoring clinical trial NCT03606486?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.